Andritz Share Price Swiss Exchange
Stocks
ANDR
AT0000730007
Industrial Machinery & Equipment
OTC Markets Traded| Market Cap | 780.07Cr 892.73Cr 721.56Cr 673.48Cr 1.26TCr 84TCr 1.27TCr 8.57TCr 3.34TCr 41TCr 3.35TCr 3.28TCr 1,44100Cr | P/E 2026 * |
16.1x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 709.03Cr 811.43Cr 655.85Cr 612.14Cr 1.15TCr 77TCr 1.16TCr 7.79TCr 3.03TCr 38TCr 3.05TCr 2.98TCr 1,31000Cr | EV / Sales 2026 * |
0.86x | EV / Sales 2027 * | 0.79x |
| Free-Float |
62.73% | Yield 2026 * |
3.55% | Yield 2027 * | 3.83% |
Last Transcript: Andritz
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 07/04/2022 | |
Vanessa Hellwing
DFI | Director of Finance/CFO | 47 | 28/03/2025 |
Susan Trast
SAM | Sales & Marketing | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wolfgang Leitner
CHM | Chairman | 73 | 08/04/2024 |
Andreas Martiner
BRD | Director/Board Member | 61 | 02/07/2010 |
Georg Auer
BRD | Director/Board Member | 51 | 01/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 892.73Cr | ||
| +0.93% | +4.71% | +47.40% | +159.33% | 12TCr | ||
| -4.59% | +2.66% | +104.66% | +50.82% | 4.6TCr | ||
| -0.05% | +1.43% | -3.13% | +22.59% | 3.05TCr | ||
| +2.61% | +3.96% | +31.18% | +60.86% | 3.09TCr | ||
| -1.48% | -2.67% | +43.47% | +48.24% | 2.84TCr | ||
| -3.03% | +4.27% | +42.45% | -9.13% | 2.9TCr | ||
| +9.83% | +18.46% | - | - | 3.08TCr | ||
| +0.31% | +0.72% | -10.20% | -0.59% | 2.66TCr | ||
| +1.45% | +6.09% | +39.87% | +47.76% | 2.41TCr | ||
| Average | +0.62% | +5.11% | +36.96% | +47.49% | 4.09TCr | |
| Weighted average by Cap. | +0.54% | +5.22% | +43.32% | +78.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 819.79Cr 938.19Cr 758.3Cr 707.77Cr 1.33TCr 89TCr 1.34TCr 9.01TCr 3.51TCr 44TCr 3.52TCr 3.45TCr 1,51400Cr | 879.07Cr 1.01TCr 813.13Cr 758.95Cr 1.42TCr 95TCr 1.44TCr 9.66TCr 3.76TCr 47TCr 3.78TCr 3.7TCr 1,62400Cr |
| Net income | 49Cr 56Cr 45Cr 42Cr 79Cr 5.29TCr 80Cr 537.55Cr 209.15Cr 2.6TCr 210.13Cr 205.57Cr 9.03TCr | 56Cr 64Cr 52Cr 48Cr 91Cr 6.07TCr 92Cr 617.4Cr 240.22Cr 2.99TCr 241.34Cr 236.11Cr 10TCr |
| Net Debt | -71Cr -81Cr -66Cr -61Cr -115.15Cr -7.68TCr -115.99Cr -780.91Cr -303.85Cr -3.78TCr -305.26Cr -298.64Cr -13TCr | -89Cr -102.18Cr -83Cr -77Cr -144.71Cr -9.66TCr -145.77Cr -981.41Cr -381.86Cr -4.75TCr -383.63Cr -375.32Cr -16TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















